Related Experiment Video
Updated: May 27, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program:
Charung Muangchana1, Narong Henprasertthae, Krissana Nurach
1National Vaccine Institute (NVI), Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand. charungm@hotmail.com
Abstract:
Mouse brain-derived, purified inactivated Japanese encephalitis vaccine (MB JEV) has been locally produced and introduced into Thai National Immunization Program (NIP) since 1990. However, MB JEV effectiveness has been concerned, since 30-40% of JE cases received JE vaccines were recently reported in two descriptive studies. Therefore, in 2010, a case-control study was designed to assess effectiveness of the MB JEV used in the NIP, among children aged 1 to <6 years. Subjects enrolled from all regions of the country, 26 cases were clinical encephalitis with laboratory-confirmed for JE IgM titer, while 103 controls had past illness free on encephalitis. For each case, four controls were enrolled from children living in the same community with the case. Individual health records of the subjects were used to verify JE immunization status. Among children aged ≥ 18 months old, the recommended age by the NIP, the effectiveness was estimated at 94.6% (95%CI, 79.6-98.6%) and adjusted effectiveness was 97.50% (95%CI, 88.60-99.50%). The study results suggest that the MB JEV used in the NIP is highly effective, even among children aged <18 months. Therefore, aggressive immunization using the MB JEV would greatly diminish disease burden.
Insights
The mouse brain-derived Japanese encephalitis vaccine (MB JEV) is highly effective in preventing Japanese encephalitis (JE) in children. Aggressive immunization programs utilizing MB JEV can significantly reduce the disease burden.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- The mouse brain-derived Japanese encephalitis vaccine (MB JEV) has been part of Thailand's National Immunization Program (NIP) since 1990.
- Concerns regarding MB JEV effectiveness arose due to recent studies reporting 30-40% of Japanese encephalitis (JE) cases occurred in vaccinated individuals.
Purpose of the Study:
- To assess the effectiveness of the MB JEV used in the Thai NIP among children aged 1 to <6 years.
- To provide evidence-based recommendations for JE vaccination strategies in Thailand.
Main Methods:
- A case-control study was conducted in 2010, enrolling 26 laboratory-confirmed JE cases and 103 age- and community-matched controls.
- Immunization status was verified using individual health records.
- Effectiveness was calculated for children aged ≥ 18 months, the NIP's recommended age.
Main Results:
- The estimated effectiveness of MB JEV among children aged ≥ 18 months was 94.6% (95% CI, 79.6-98.6%).
- Adjusted effectiveness reached 97.50% (95% CI, 88.60-99.50%).
- The vaccine demonstrated high effectiveness even in children vaccinated before 18 months.
Conclusions:
- The MB JEV utilized in the NIP demonstrates high effectiveness in preventing JE.
- The findings support continued and potentially expanded immunization efforts with MB JEV to reduce JE disease burden.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

